$118.42-0.47 (-0.40%)
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
iRhythm Holdings, Inc. in the Healthcare sector is trading at $118.42 with a market capitalization of $3.6B. Wall Street consensus targets $178.93 (14 analysts), implying a +51.1% move over the next 12 months. The stock is currently near its 52-week low of $100.85, remaining 20.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $199.39M↓ | $208.89M↑ | $192.88M↑ | $186.69M↑ | $158.68M |
| Gross Profit | $141.35M↓ | $148.06M↑ | $137.12M↑ | $132.86M↑ | $109.22M |
| Operating Income | -$16.18M↓ | $4.26M↑ | -$8.43M↑ | -$16.23M↑ | -$32.56M |
| Net Income | -$13.93M↓ | $5.58M↑ | -$5.21M↑ | -$14.22M↑ | -$30.70M |
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company ...
Carillon Tower Advisers, an investment management company, released its first-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. A copy of the letter can be downloaded here. Small-cap stocks delivered mixed results in the quarter as the market favored value stocks over growth. The Russell 2000 Growth Index fell 2.82% in the quarter, […]
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
iRhythm Holdings (IRTC) is back in focus after shareholders approved an amended Certificate of Incorporation and the company entered a settlement agreement related to earlier class action securities litigation, which is sharpening attention on governance and risk. See our latest analysis for iRhythm Holdings. Recent governance changes and the litigation settlement are playing out against a weaker share price backdrop, with the stock at US$108.11 and the year to date share price return down...
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Small Cap Fund”. A copy of the letter is available to download here. US equities were mixed in Q1 2026, with major indices hitting all-time highs in January before retreating amid geopolitical tensions, changing monetary policy, and economic uncertainty. Energy […]